What breakthrough has the Abu Dhabi Stem Cells Centre (ADSCC) achieved?

For the first time in the UAE, ADSCC has successfully isolated Tumour-Infiltrating Lymphocytes (TILs) from breast and lung tumours, paving the way for the country’s inaugural TIL therapy program. This cutting-edge immunotherapy uses a patient’s own immune cells to target and destroy cancer, representing a major step in personalised medicine. Approved by the Department of Health – Abu Dhabi as an observational study, the initiative could transform cancer treatment in the region. How do you feel about the potential of TIL therapy for patients in the UAE?

Add your Comment:

+